These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15586175)

  • 1. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations.
    Vink GR; White SJ; Gabelic S; Hogendoorn PC; Breuning MH; Bakker E
    Eur J Hum Genet; 2005 Apr; 13(4):470-4. PubMed ID: 15586175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas.
    Pedrini E; De Luca A; Valente EM; Maini V; Capponcelli S; Mordenti M; Mingarelli R; Sangiorgi L; Dallapiccola B
    Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients.
    Signori E; Massi E; Matera MG; Poscente M; Gravina C; Falcone G; Rosa MA; Rinaldi M; Wuyts W; Seripa D; Dallapiccola B; Fazio VM
    Genes Chromosomes Cancer; 2007 May; 46(5):470-7. PubMed ID: 17301954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas.
    Jennes I; Entius MM; Van Hul E; Parra A; Sangiorgi L; Wuyts W
    J Mol Diagn; 2008 Jan; 10(1):85-92. PubMed ID: 18165274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
    Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
    J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
    Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
    Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).
    Jennes I; Pedrini E; Zuntini M; Mordenti M; Balkassmi S; Asteggiano CG; Casey B; Bakker B; Sangiorgi L; Wuyts W
    Hum Mutat; 2009 Dec; 30(12):1620-7. PubMed ID: 19810120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1.
    Li H; Yamagata T; Mori M; Momoi MY
    J Hum Genet; 2002; 47(5):262-5. PubMed ID: 12032595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
    Wuyts W; Van Hul W
    Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses.
    White SJ; Vink GR; Kriek M; Wuyts W; Schouten J; Bakker B; Breuning MH; den Dunnen JT
    Hum Mutat; 2004 Jul; 24(1):86-92. PubMed ID: 15221792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EXT1 and EXT2 mutation identified by denaturing high performance liquid chromatograph in three families with hereditary multiple exostoses].
    Zhang M; Liu SG; Li FF; Zhou WH; Jin XH; Ma X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):646-51. PubMed ID: 18067075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation screening of EXT genes in Chinese patients with multiple osteochondromas.
    Kang Z; Peng F; Ling T
    Gene; 2012 Sep; 506(2):298-300. PubMed ID: 22820392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses.
    Raskind WH; Conrad EU; Matsushita M; Wijsman EM; Wells DE; Chapman N; Sandell LJ; Wagner M; Houck J
    Hum Mutat; 1998; 11(3):231-9. PubMed ID: 9521425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.
    Jennes I; de Jong D; Mees K; Hogendoorn PC; Szuhai K; Wuyts W
    BMC Med Genet; 2011 Jun; 12():85. PubMed ID: 21703028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From gene to disease; hereditary multiple exostoses].
    Wuyts W; Bovée JV; Hogendoorn PC
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A splice-site mutation leads to haploinsufficiency of EXT2 mRNA for a dominant trait in a large family with multiple osteochondromas.
    Yang L; Hui WS; Chan WC; Ng VC; Yam TH; Leung HC; Huang JD; Shum DK; Jie Q; Cheung KM; Cheah KS; Luo Z; Chan D
    J Orthop Res; 2010 Nov; 28(11):1522-30. PubMed ID: 20872591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients.
    Szuhai K; Jennes I; de Jong D; Bovée JV; Wiweger M; Wuyts W; Hogendoorn PC
    Hum Mutat; 2011 Feb; 32(2):E2036-49. PubMed ID: 21280143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mutations in EXT1 and EXT2 in Brazilian patients with multiple osteochondromas.
    Santos SCL; Rizzo IMPO; Takata RI; Speck-Martins CE; Brum JM; Sollaci C
    Mol Genet Genomic Med; 2018 May; 6(3):382-392. PubMed ID: 29529714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.